EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE FOR 48 WEEKS IN HBEAG- POSITIVE CHB PATIENTS: A REAL- WORLD, MULTICENTER COHORT STUDY

Han, JJ; Zhang, JM; Zhang, YM; Zhang, Y; Guo, YF; Yang, FF; Mao, RC; Zhang, XY

HEPATOLOGY, 2023; 78 (): S517